InvestorsHub Logo
Followers 7
Posts 354
Boards Moderated 0
Alias Born 08/12/2019

Re: Pharmacydude post# 368730

Friday, 02/04/2022 8:01:56 AM

Friday, February 04, 2022 8:01:56 AM

Post# of 426487
Appreciate your pow and often I do agree with you. However, there is some way between not recommending a drug due to lack of trustworthy effect to rejecting it based on price.
Unless management or the experts from IH can persuade NICE through comments and/or appeal we are looking at a longer period of not being covered in UK.
Not sure how appeal process work but management better step up or they will blow Europe too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News